← Back

Mirion Technologies Inc

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company also offers include radiation measurement and monitoring solutions, reactor instrumentation and control detectors, imaging systems and cameras, and waste management systems; laboratory and scientific analysis systems comprising gamma/alpha spectroscopy, alpha/beta counting, specialty detectors, and spectroscopy software; radiation measurement and health physics instrumentation; and contamination and clearance monitors. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. Mirion Technologies, Inc. was incorporated in 2005 and is headquartered in Atlanta, Georgia.

Price · split & dividend adjusted
News & notes moving MIR
MIR

Mirion Technologies to report Q2 2026 earnings on July 28

Mirion Technologies is scheduled to announce its second-quarter 2026 earnings results on Tuesday, July 28, after market close. The consensus earnings per share estimate is $0.10, representing a 9.1% decline year-over-year, while the consensus revenue estimate is $269.63 million, up 21.0% from the prior year. Over the past two years, the company has beaten EPS estimates 75% of the time and revenue estimates 75% of the time. In the last three months, EPS estimates have seen zero upward revisions and seven downward revisions, and revenue estimates have seen zero upward revisions and six downward revisions.
MIR
Seeking Alpha·30dRead more ▾
Energy Transition & Power Demand

Mirion Technologies Stock Declines Despite Bullish Fair Value Narrative

Mirion Technologies shares have fallen 10.12% over the past month and 14.36% over three months to $16.88, even as the most followed analyst narrative pegs fair value at $27.90, implying the stock is 39.5% undervalued. That bullish case rests on accelerating order intake from advanced nuclear projects, including utility-scale new builds and small modular reactors, which could drive step-changes in backlog and revenue. However, the current price-to-sales ratio of 4.2 times exceeds both the estimated fair ratio of 3.8 times and the US Electronic industry average of 2.9 times, raising questions about how much optimism is already priced in. Key risks include reliance on nuclear sector spending and execution challenges tied to the company's acquisition-led growth strategy.
MIR
Energy Transition & Power Demand ▲
Simply Wall St·34dRead more ▾
MIR▲

3 Big Reasons to Love Mirion

Mirion Technologies has seen its stock price fall 20.3% over the past six months to $18.93 per share, but the company’s fundamentals remain strong. Sales grew at a 10.8% compounded annual rate over the last five years, outpacing the average business services company. Adjusted operating margin rose by 10.5 percentage points over the same period, reaching 7.9% for the trailing 12 months. Free cash flow margin expanded by 8.7 percentage points, hitting 9.1% for the trailing 12 months, giving the company more financial flexibility.
MIR ▲
Yahoo Finance·61dRead more ▾
MIR

Mirion leads specialized tech revenue growth in Q1 but shares flat

Mirion Technologies reported first-quarter revenues of $257.6 million, up 27.5% year on year and beating analyst estimates by 5.2%, making it the fastest-growing among eight specialized technology stocks tracked. The broader group posted a very strong quarter overall, with aggregate revenues exceeding consensus by 4.2% and next-quarter guidance coming in 3.9% above expectations. Despite the strong results, share prices across the group have declined 3.9% on average since reporting. Mirion's stock is flat since its release, trading at $18.50, while Cognex delivered the biggest beat and highest guidance raise, and OSI Systems recorded the slowest growth and weakest guidance update.
MIR CGNX ▲OSIS ▼
StockStory·64dRead more ▾
Energy Transition & Power Demand▲

Paragon Awarded Contract to Complete Final Design Work for NuScale Power's Small Modular Reactor

Paragon, a Mirion Technologies company, has been awarded a contract by NuScale Power to complete final design development of its Highly Integrated Protection System for the NuScale Power Module. The contract covers non-recurring engineering and design deliverables for three critical instrumentation and control systems: the Module Protection System, the Safety Data Interface System, and the Plant Protection System, along with Independent Verification and Validation services for the Module Protection System. NuScale already has certain components of 12 power modules in production, and plants deploying these modules are expected to feature one common control room supporting up to 12 modules, each capable of generating up to 77 megawatts of clean power. NuScale's design is the first and only small modular reactor to be approved by the U.S. Nuclear Regulatory Commission. The HIPS platform was purpose-built for next-generation reactor designs and received NRC Safety Evaluation Report approval of its topical report in 2017, co-developed with NuScale.
SMR ▲MIR ▲
Energy Transition & Power Demand ▲
Business Wire·70dRead more ▾
© 2026 MarketDXAsset